Reata Pharmaceuticals, Inc.
RETANASDAQHealthcare
$172.36
+$0.04(+0.02%)
Market Cap$6.6B
P/E Ratio—
52W High$172.46
52W Low$21.83
Reata Pharmaceuticals, Inc. (RETA) Stock Price History
Key milestones, OHLCV table, annual returns, peers & What If.
reta · EOD price history · split-adj. · FMP · as of Sep 26, 2023
5-Year High5Y
$172.46
Sep 25, 2023
-0.1% from here
5-Year Low5Y
$18.47
Aug 17, 2022
+833.2% from low
IPO Priceadj.
$13.07
May 26, 2016
+1.2K% since IPO
1 Year Ago
—
—
+0.0% in 1Y
5 Years Ago
$141.40
Jun 9, 2021
+21.9% in 5Y
10 Years Ago
$23.15
Jun 9, 2016
+644.5% in 10Y
Historical Price Data · RETA
| Date↓ | Open↕ | High↕ | Low↕ | Close↕ | Close (Unadj.) ⓘ | Volume↕ | Change %↕ |
|---|---|---|---|---|---|---|---|
| Sep 26, 2023 | $172.36 | $172.36 | $172.36 | $172.36 | $172.36 | 0K | +0.00% |
| Sep 25, 2023 | $172.34 | $172.46 | $172.32 | $172.36 | $172.36 | 2.0M | +0.01% |
| Sep 22, 2023 | $172.29 | $172.34 | $172.25 | $172.32 | $172.32 | 749K | +0.02% |
| Sep 21, 2023 | $172.22 | $172.36 | $172.12 | $172.17 | $172.17 | 1.9M | -0.03% |
| Sep 20, 2023 | $172.10 | $172.21 | $172.10 | $172.21 | $172.21 | 518K | +0.06% |
| Sep 19, 2023 | $172.00 | $172.15 | $171.96 | $172.11 | $172.11 | 423K | +0.06% |
| Sep 18, 2023 | $172.00 | $172.08 | $171.76 | $172.05 | $172.05 | 486K | +0.03% |
| Sep 15, 2023 | $172.05 | $172.15 | $171.75 | $172.00 | $172.00 | 904K | -0.03% |
| Sep 14, 2023 | $172.00 | $172.10 | $171.98 | $172.06 | $172.06 | 391K | +0.03% |
| Sep 13, 2023 | $172.00 | $172.10 | $171.95 | $172.00 | $172.00 | 1.1M | +0.00% |
| Sep 12, 2023 | $170.54 | $172.05 | $170.32 | $171.98 | $171.98 | 1.7M | +0.84% |
| Sep 11, 2023 | $170.41 | $171.12 | $170.25 | $170.94 | $170.94 | 1.1M | +0.31% |
| Sep 8, 2023 | $169.75 | $170.39 | $169.70 | $170.32 | $170.32 | 548K | +0.34% |
| Sep 7, 2023 | $169.56 | $170.26 | $169.56 | $170.15 | $170.15 | 695K | +0.35% |
| Sep 6, 2023 | $169.38 | $169.80 | $169.38 | $169.63 | $169.63 | 336K | +0.15% |
| Sep 5, 2023 | $168.67 | $169.98 | $168.67 | $169.79 | $169.79 | 642K | +0.66% |
| Sep 1, 2023 | $168.90 | $169.50 | $168.90 | $169.26 | $169.26 | 366K | +0.21% |
| Aug 31, 2023 | $168.84 | $169.26 | $168.74 | $169.00 | $169.00 | 659K | +0.09% |
| Aug 30, 2023 | $169.14 | $169.17 | $168.67 | $168.70 | $168.70 | 457K | -0.26% |
| Aug 29, 2023 | $169.19 | $169.20 | $168.80 | $168.88 | $168.88 | 625K | -0.18% |
Showing 1–20 of 578 records
Annual Stock Price Performance · RETA
Jan 1 → Dec 31 · 3 years2023+346.3%$38.62 → $172.36
+346.3%
2022+42.4%$26.67 → $37.99
+42.4%
2021-81.3%$140.71 → $26.37
-81.3%
Best Year2023 · +346.3%
Worst Year2021 · -81.3%
Positive Years2 / 3
Avg Annual Return+102.5%
3Y Total Return+22.5%
3Y CAGR~+7.0% / yr
Similar Companies in Healthcare
View sector
Eli Lilly and Company
LLY.TO
$41.30+0.00%
Mkt Cap $1.43T
Eli Lilly and Company
LLY
$1,149.15+0.00%
Mkt Cap $1.08T
Johnson & Johnson
JNJ
$232.16+0.00%
Mkt Cap $558.9B
AbbVie Inc.
ABBV
$223.07+0.00%
Mkt Cap $394.1B
UnitedHealth Group Incorporated
UNH
$406.57+0.00%
Mkt Cap $369.2B
Merck & Co., Inc.
MRK
$119.52+0.00%
Mkt Cap $295.2B
AstraZeneca PLC
AZN
$181.55+0.00%
Mkt Cap $281.6B
Novartis AG
NVS
$146.42+0.00%
Mkt Cap $279.4B
Amgen Inc.
AMGN
$345.73+0.00%
Mkt Cap $186.6B
Novo Nordisk A/S
NVO
$41.02+0.00%
Mkt Cap $182.3BWhat If You Invested in RETA?
If you invested $1,000 in RETA 10 years ago — how much would it be worth today?
INVESTED$1,000
→TODAY WORTH$7,445
Total Return+644.5%
CAGR~+22.2% / yr
Profit+$6,445
Based on Jun 9, 2016 · $23.15Split & dividend adjustedNo fees assumed
Want a detailed breakdown?
Try the full calculator with custom amounts, dates & DRIP.
Full Calculator →Try the full calculator with custom amounts, dates & DRIP.
About Price History & OHLCV Data
Reata Pharmaceuticals, Inc. (RETA) is classified under Healthcare and trades on NASDAQ. The quote snapshot on this page shows a last price of $172.36. Use the chart and OHLCV table below for open, high, low, close and volume over time.
Annual performance bars, similar companies in the same sector, and the What If calculator help you explore long-horizon returns without leaving this tab. Figures use split-adjusted end-of-day prices where noted; this content is informational, not investment advice.
Data: FMP EOD · split-adjusted where noted · not investment advice
Frequently Asked Questions
RETA price history · 5 questionsEnd-of-day prices are sourced from market data providers (Financial Modeling Prep). Corporate actions such as splits may be reflected in adjusted series; always verify critical values with your broker or official filings.
RETA historical stock pricesFMP EOD datasplit-adjusted OHLCV